BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9286307)

  • 1. Increased serum CA125 levels in plasma cell dyscrasias.
    Iwasaki T; Hamano T; Aizawa K; Kobayashi K; Kakishita E
    Acta Haematol; 1997; 98(2):104-8. PubMed ID: 9286307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum tumor markers (CA125 and CA15.3) in primary plasma cell leukemia: a case report and review of the literature.
    de Larrea CF; Cibeira MT; Vallansot R; Colomo L; Bladé J
    Clin Lymphoma Myeloma; 2008 Oct; 8(5):312-4. PubMed ID: 18854288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmacytoma of lymph nodes.
    Addis BJ; Isaacson P; Billings JA
    Cancer; 1980 Jul; 46(2):340-6. PubMed ID: 6770994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of CA125, CA19-9, and Ki-67 in stage III or IV endometriosis: positive correlation between serum CA125 level and endometriotic epithelial cell proliferation.
    Toki T; Kubota J; Lu X; Nakayama K
    Acta Obstet Gynecol Scand; 2000 Sep; 79(9):771-6. PubMed ID: 10993101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
    Mayo MM; Johns GS
    Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgE myeloma with elevated level of serum CA125.
    Wang ML; Huang Q; Yang TX
    J Zhejiang Univ Sci B; 2009 Jul; 10(7):559-62. PubMed ID: 19585675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum CA125 level associated with disease activity in a patient with follicular lymphoma].
    Kuroda H; Kida M; Watanabe H; Shirao S; Konda K
    Rinsho Ketsueki; 2005 Apr; 46(4):281-3. PubMed ID: 16444962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemorheological and coagulation aspects in plasmacytoma].
    Reali GL; Cella A; Piana A; Armani U
    Boll Soc Ital Biol Sper; 1989 Oct; 65(10):923-9. PubMed ID: 2624709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Soluble syndecan-1 levels in different plasma cell dyscrasias].
    Jánosi J; Sebestyén A; Mikala G; Petö M; Jákó J; Domján G; Németh J; Kis Z; Kopper L; Vályi-Nagy I
    Orv Hetil; 2005 Jan; 146(4):165-8. PubMed ID: 15751511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum CA125: a useful marker for surgical management of endometrial cancer.
    Jiang T; Huang L; Zhang S
    BMC Cancer; 2015 May; 15():396. PubMed ID: 25964114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperviscosity syndrome in a patient with plasma cell leukemia.
    Douer D; Weinbergerr A; Djaldetti M; Asherov J; Pick I; Pinkhas J
    Acta Haematol; 1979; 62(2):81-5. PubMed ID: 119405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal trauma preceding the development of plasma cell dyscrasia: eight case reports and review of the literature.
    Hussein MA; George R; Rybicki L; Karam MA
    Med Oncol; 2003; 20(4):349-54. PubMed ID: 14716030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer.
    Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM
    Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.
    Bataille R; Jourdan M; Zhang XG; Klein B
    J Clin Invest; 1989 Dec; 84(6):2008-11. PubMed ID: 2592570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease.
    Levinson SS
    Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [IL-6, p53 and proto-oncogene c-myc play different roles as biological markers of plasma cell dyscrasias].
    Alvino S; Marcucci M; Canzoniere D; Mosiello A; Del Monte G; Venturo I; Rinaldi M; Gandolfo GM; Lopez M; Greco C
    Clin Ter; 1999; 150(3):197-202. PubMed ID: 10528431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
    Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS
    Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of preoperative serum CA125 in early-stage adenocarcinoma of the uterine cervix without pelvic lymph node metastasis.
    Tsai CC; Liu YS; Huang EY; Huang SC; Chang HW; Tseng CW; ChangChien CC
    Gynecol Oncol; 2006 Mar; 100(3):591-5. PubMed ID: 16290001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers.
    Dai H; Liu J; Liang L; Ban C; Jiang J; Liu Y; Ye Q; Wang C
    Respirology; 2014 Jul; 19(5):707-13. PubMed ID: 24903079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum interleukin-11 in plasma-cell dyscrasias.
    Stasi R; Brunetti M; Bussa S; Catucci AE; Pagano A; Amadori S
    Am J Hematol; 1996 Nov; 53(3):206-7. PubMed ID: 8895699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.